1型糖尿病患者中赖脯胰岛素的剂量-反应关系。 - Suppr

Suppr

超能文献

Dose-response relationship of insulin glulisine in subjects with type 1 diabetes.

作者信息

Becker Reinhard H A, Frick Annke D, Nosek Leszek, Heinemann Lutz, Rave Klaus

机构信息

sanofi-aventis, Building H831, Room C 0441, Frankfurt, Germany.

出版信息

Diabetes Care. 2007 Oct;30(10):2506-7. doi: 10.2337/dc06-2114. Epub 2007 Aug 3.

DOI:10.2337/dc06-2114

PMID:17675541

Abstract

摘要

相似文献

Dose-response relationship of insulin glulisine in subjects with type 1 diabetes.

Diabetes Care. 2007 Oct;30(10):2506-7. doi: 10.2337/dc06-2114. Epub 2007 Aug 3.

[Clinical aspects of Insulin Lispro (LY275585)].

Nihon Rinsho. 1997 Nov;55 Suppl:298-305.

Impaired absorption of insulin aspart from lipohypertrophic injection sites.

Diabetes Care. 2005 Aug;28(8):2025-7. doi: 10.2337/diacare.28.8.2025.

Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment.

Diabetes Care. 2003 Apr;26(4):1321-2. doi: 10.2337/diacare.26.4.1321.

Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes.

Diabetes Care. 2007 May;30(5):1261-3. doi: 10.2337/dc06-2208. Epub 2007 Feb 15.

Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvidøre Study Group on Childhood Diabetes.

Diabet Med. 1998 Sep;15(9):752-9. doi: 10.1002/(SICI)1096-9136(199809)15:9<752::AID-DIA678>3.0.CO;2-W.

[Taking the peak out of blood pressure. Diabetics can also live spontaneously].

MMW Fortschr Med. 1999 Dec 9;141(49-50):66-7.

Updating the insulin lispro file.

CMAJ. 1998 May 5;158(9):1132-3.

[From human insulin to designer insulin. Why insulin analogs?].

Fortschr Med. 1997 Apr 30;115(12):40-1.

The pharmacokinetic and pharmacodynamic properties of different formulations of biphasic insulin aspart: a randomized, glucose clamp, crossover study.

Diabetes Technol Ther. 2008 Dec;10(6):479-85. doi: 10.1089/dia.2008.0019.

引用本文的文献

Fast-Acting Insulin Aspart: A Review of its Pharmacokinetic and Pharmacodynamic Properties and the Clinical Consequences.

Clin Pharmacokinet. 2020 Feb;59(2):155-172. doi: 10.1007/s40262-019-00834-5.

A Population Dose-Response Model for Inhaled Technosphere Insulin Administered to Healthy Subjects.

CPT Pharmacometrics Syst Pharmacol. 2017 Jun;6(6):365-372. doi: 10.1002/psp4.12189. Epub 2017 Jun 1.

Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus.

Clin Pharmacokinet. 2017 Jun;56(6):649-660. doi: 10.1007/s40262-016-0473-5.

Improved Postprandial Glucose Control Using the InsuPad Device in Insulin-Treated Type 2 Diabetes: Injection Site Warming to Improve Glycemic Control.

J Diabetes Sci Technol. 2015 May;9(3):639-43. doi: 10.1177/1932296815578881. Epub 2015 Apr 16.

Confusion Regarding Duration of Insulin Action: A Potential Source for Major Insulin Dose Errors by Bolus Calculators.

J Diabetes Sci Technol. 2014 Jan;8(1):170-178. doi: 10.1177/1932296813514319. Epub 2014 Jan 1.

Increasing local blood flow by warming the application site: beneficial effects on postprandial glycemic excursions.

J Diabetes Sci Technol. 2012 Jul 1;6(4):780-5. doi: 10.1177/193229681200600407.

Continuous glucose monitoring-guided insulin dosing in pump-treated patients with type 1 diabetes: a clinical guide.

J Diabetes Sci Technol. 2012 Jan 1;6(1):191-203. doi: 10.1177/193229681200600124.

Comparable efficacy and safety of insulin glulisine and insulin lispro when given as part of a Basal-bolus insulin regimen in a 26-week trial in pediatric patients with type 1 diabetes.

Diabetes Technol Ther. 2011 Mar;13(3):327-34. doi: 10.1089/dia.2010.0072. Epub 2011 Feb 3.

Comparative pharmacodynamic and pharmacokinetic characteristics of subcutaneous insulin glulisine and insulin aspart prior to a standard meal in obese subjects with type 2 diabetes.

Diabetes Obes Metab. 2011 Mar;13(3):251-7. doi: 10.1111/j.1463-1326.2010.01343.x.

Insulin glulisine: a review of its use in the management of diabetes mellitus.

Drugs. 2009 May 29;69(8):1035-57. doi: 10.2165/00003495-200969080-00006.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验